Clinical Trial Update: Cellular Immunotherapy Following Chemotherapy in Treating Patients With Recurrent Non-Hodgkin Lymphomas, Chronic Lymphocytic Leukemia, or B-Cell Prolymphocytic Leukemia [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating cellular immunotherapy after chemotherapy in patients with recurrent B-cell lymphoid cancers, including Non-Hodgkin lymphoma, Chronic l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Prolymphocytic Leukemia
• Chronic Lymphocytic Leukemia
• Non-hodgkin Lymphoma

Drugs mentioned

• Cellular immunotherapy following chemotherapy

Snippet

Sponsor: City of Hope Medical Center | Conditions: B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma, B-Cell Prolymphocytic Leukemia | Phase 1 | Status: ACTIVE_NOT_RECRUITING